<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-BOI-3207</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-3207</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SHORT COMMUNICATIONS</subject></subj-group></article-categories><title-group><article-title>Маркеры воспалительного старения при гериатрических синдромах</article-title><trans-title-group xml:lang="en"><trans-title>Biomarkers of inflammaging in geriatric syndromes</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3218-1996</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лукьянова</surname><given-names>С. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Lukyanova</surname><given-names>S. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лукьянова Светлана Олеговна - ассистент кафедры иммунологии </p><p>117513, Москва ул. Островитянова, 1 </p><p> Тел.: 8 (915) 182-37-62 </p></bio><bio xml:lang="en"><p>Assistant Professor, Department of Immunology </p><p>1 Ostrovitianov St Moscow 117513 </p><p>Phone: +7 (915) 182-37-62 </p></bio><email xlink:type="simple">lukyanovasv@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2582-3372</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Греченко</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Grechenko</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>К.м.н., доцент кафедры иммунологии </p><p>Москва </p></bio><bio xml:lang="en"><p>PhD (Medicine), Associate Professor, Department of Immunology </p><p>Moscow </p></bio><email xlink:type="simple">grechenko_v@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9957-6063</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Артемьева</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Artemieva</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>К.м.н., доцент кафедры иммунологии </p><p>Москва </p></bio><bio xml:lang="en"><p>PhD (Medicine), Associate Professor, Department of Immunology </p><p>Moscow </p></bio><email xlink:type="simple">artemyevaov@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3657-0676</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Стражеско</surname><given-names>И. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Strajesko</surname><given-names>I. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Д.м.н., профессор, заместитель директора по трансляционной медицине  </p><p>Москва </p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Deputy Director for Translational Medicine </p><p>Moscow </p></bio><email xlink:type="simple">istrazhesko@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1271-3078</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ганковская</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gankovskaya</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Д.м.н., профессор, профессор кафедры иммунологии </p><p>Москва </p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Department of Immunology </p><p>Moscow </p></bio><email xlink:type="simple">lvgan@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГАОУ ВО «Российский национальный исследовательский медицинский университет имени Н.И. Пирогова» Министерства здравоохранения РФ<country>Россия</country></aff><aff xml:lang="en">N. Pirogov Russian National Research Medical University<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>06</day><month>06</month><year>2025</year></pub-date><volume>27</volume><issue>3</issue><fpage>643</fpage><lpage>650</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Лукьянова С.О., Греченко В.В., Артемьева О.В., Стражеско И.Д., Ганковская Л.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Лукьянова С.О., Греченко В.В., Артемьева О.В., Стражеско И.Д., Ганковская Л.В.</copyright-holder><copyright-holder xml:lang="en">Lukyanova S.O., Grechenko V.V., Artemieva O.V., Strajesko I.D., Gankovskaya L.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/3207">https://www.mimmun.ru/mimmun/article/view/3207</self-uri><abstract><p>Общемировая тенденция к увеличению продолжительности жизни делает изучение аспектов старения и возраст-ассоциированной патологии актуальным. Патофизиологические механизмы, лежащие в основе гериатрических синдромов, остаются недостаточно изученными, предполагают, что хроническое стерильное воспаление (inflammaging) может быть ключевым фактором, который связывает старческую астению и саркопению. Группами ученых ведутся работы по поиску биомаркеров, ассоциированных с различными фенотипами старения, среди наиболее изученных иммунологических маркеров старения выделяют IL-1β, IL-6, TNFα, С-реактивный белок. Исследование посвящено комплексной оценке уровня экспрессии гена паттерн-распознающего рецептора TLR2, генов цитокинов IL-1β, IL-6, IL-10 и содержания цитокинов IL-1β, IL-6, IL-10 у долгожителей с синдромом старческой астении, саркопенией. В работу были включены 219 долгожителей, которым была проведена комплексная гериатрическая оценка в соответствии с действующими клиническими рекомендациями. Была выделена подгруппа, включающая 161 пациента, соответствующих критериям однородности по сопутствующей патологии с использованием индекса коморбидности Чарлсона. Далее были выделены клинические группы долгожителей по гериатрическим синдромам с наличием старческой астении (n = 77) и отсутствием старческой астении (n = 84), с наличием саркопении (n = 130) и ее отсутствием (n = 31). Показано, что синдром старческой астении сопровождается увеличением экспрессии гена TLR2, генов провоспалительных цитокинов IL-1β и IL-6, повышением концентрации цитокина IL-6 в сыворотке крови по сравнению с группой без этого синдрома. Установлено, что саркопения сочетается с повышением экспрессии гена IL6, продукции цитокинов IL-1β и IL-6, а также снижением экспрессии гена и продукции противовоспалительного цитокина IL-10 по сравнению с группой без саркопении. Выявлено, что у долгожителей с саркопенией соотношение концентрации цитокинов IL-6/IL-10 в 5 раз выше, чем у долгожителей без саркопении, а у пациентов с астенией – в 3,4 раза выше, чем у долгожителей без этого синдрома. Увеличение показателя IL-6/IL-10 ассоциировались с высокой вероятностью развития астении и саркопении. Таким образом, полученные в ходе исследования результаты подтверждают участие воспалительного старения в патогенезе гериатрических синдромов у долгожителей. Соотношение IL-6/IL-10, характеризующее дисбаланс про- и противовоспалительных факторов в сыворотке крови долгожителей, можно рассматривать как потенциальный маркер выраженности воспаления и развития старческой астении и саркопении.</p></abstract><trans-abstract xml:lang="en"><p>The worldwide trend towards increasing life expectancy makes relevant the studies on aging and ageassociated pathology. The pathophysiologic mechanisms underlying geriatric syndromes remain insufficiently studied. It is hypothesized that chronic sterile inflammation (inflammaging) may be a key factor that links senile asthenia and sarcopenia. Several scientific teams are searching for biomarkers associated with different aging phenotypes. IL-1β, IL-6, TNFα, and C-reactive protein are among the most studied immunologic markers of aging. The study is devoted to a comprehensive evaluation of expression leveld of TLR2 patternrecognizing receptor gene as well as IL-1β, IL-6, IL-10 cytokine genes, and the contents of IL-1β, IL-6, IL-10 cytokines in long-livers with senile asthenia and sarcopenia. We included 219 nonagenarians who underwent a comprehensive geriatric evaluation according to current clinical guidelines. A subgroup including 161 patients meeting the homogeneity criteria for comorbidity was assessed by the Charlson comorbidity index. Further on, the clinical groups of long-livers were identified according to geriatric syndromes with the presence of senile asthenia (n = 77) and absence of frailty (n = 84); with sarcopenia (n = 130), and free of sarcopenia (n = 31). It was shown that the frailty is accompanied by increased expression of TLR2 gene, genes of proinflammatory cytokines IL-1β and IL-6, increased concentration of serum cytokine IL-6 compared to the group without this syndrome. It was found that sarcopenia is combined with increased IL6 gene expression, IL-1β and IL-6 cytokine production, and decreased gene expression and production of anti-inflammatory cytokine IL-10 compared to the group without sarcopenia. The ratio of IL-6/IL-10 cytokine concentration was found to be 5 times higher in long-livers with sarcopenia than in nonagenarians without sarcopenia, being 3.4 times higher in patients with senile asthenia than in nonagenarians without this syndrome. Increased IL-6/IL-10 ratio was associated with high probability of developing frailty and sarcopenia. Hence, the results of our study confirm the involvement of inflammatory aging in pathogenesis of geriatric syndromes in long-livers. The IL-6/IL-10 ratio, which characterizes the imbalance of pro- and anti-inflammatory factors in blood serum of nonagenarians, may be considered a potential marker of inflammation severity, evolving frailty and sarcopenia.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>воспалительное старение</kwd><kwd>долголетие</kwd><kwd>экспрессия генов</kwd><kwd>цитокины</kwd><kwd>синдром старческой астении</kwd><kwd>саркопения</kwd></kwd-group><kwd-group xml:lang="en"><kwd>inflammaging</kwd><kwd>longevity</kwd><kwd>gene expression</kwd><kwd>frailty</kwd><kwd>cytokine</kwd><kwd>sarcopenia</kwd></kwd-group><funding-group xml:lang="ru"><funding-statement>Исследование выполнено при поддержке гранта Российского научного фонда № 23-15-00137, http://rscf.ru/project/23-15-00137/.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Горошко Н.В., Пацала С.В. Долгожители в демографической структуре населения России // Социально-трудовые исследования. 2023. Т. 50, № 1. С. 131-144. [Goroshko N.V., Patsala S.V. Centenarians in the demographic structure of the Russian population. Sotsialno-trudovye issledovaniya = Social and Labor Research, 2023, Vol. 50, no. 1, pp. 131-144. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Goroshko N.V., Patsala S.V. Centenarians in the demographic structure of the Russian population. Sotsialno-trudovye issledovaniya = Social and Labor Research, 2023, Vol. 50, no. 1, pp. 131-144. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Лукьянова С.О., Артемьева О.В., Стражеско И.Д., Ганковская Л.В. Экспрессия генов TLR2, IL-1β, IL-10 как возможный фактор успешного или патологического старения у долгожителей // Бюллетень экспериментальной биологии и медицины, 2023. Т. 176, № 10. С. 510-513. [Lukyanova S.O., Artemyeva O.V., Strazhesko I.D., Nasaeva E.D., Grechenko V.V., Gankovskaya L.V. Expression of TLR2, IL-1β, IL-10 genes as a possible factor of successful or pathological aging in nonagenarians. Byulleten eksperimentalnoy biologii i meditsiny = Bulletin of Experimental Biology and Medicine, 2023, Vol. 176, no. 10, pp. 510-513. (In Russ.)]</mixed-citation><mixed-citation xml:lang="en">Lukyanova S.O., Artemyeva O.V., Strazhesko I.D., Nasaeva E.D., Grechenko V.V., Gankovskaya L.V. Expression of TLR2, IL-1β, IL-10 genes as a possible factor of successful or pathological aging in nonagenarians. Byulleten eksperimentalnoy biologii i meditsiny = Bulletin of Experimental Biology and Medicine, 2023, Vol. 176, no. 10, pp. 510-513. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Byrne T., Cooke J., Bambrick P., McNeela E., Harrison M. Circulating inflammatory biomarker responses in intervention trials in frail and sarcopenic older adults: A systematic review and meta-analysis. Exp. Gerontol., 2023, Vol. 177, 112199. doi: 10.1016/j.exger.2023.112199.</mixed-citation><mixed-citation xml:lang="en">Byrne T., Cooke J., Bambrick P., McNeela E., Harrison M. Circulating inflammatory biomarker responses in intervention trials in frail and sarcopenic older adults: A systematic review and meta-analysis. Exp. Gerontol., 2023, Vol. 177, 112199. doi: 10.1016/j.exger.2023.112199.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Colleselli K., Stierschneider A., Wiesner C. An update on toll-like receptor 2, its function and dimerization in pro- and anti-inflammatory processes. Int. J. Mol. Sci., 2023, Vol. 24, no. 15, 12464. doi: 10.3390/ijms241512464.</mixed-citation><mixed-citation xml:lang="en">Colleselli K., Stierschneider A., Wiesner C. An update on toll-like receptor 2, its function and dimerization in pro- and anti-inflammatory processes. Int. J. Mol. Sci., 2023, Vol. 24, no. 15, 12464. doi: 10.3390/ijms241512464.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Fan Z., Yang J.Y., Guo Y., Liu Y.X., Zhong X.Y. Altered levels of circulating mitochondrial DNA in elderly people with sarcopenia: Association with mitochondrial impairment. Exp. Gerontol., 2022, Vol. 163, 111802. doi: 10.1016/j.exger.2022.111802.</mixed-citation><mixed-citation xml:lang="en">Fan Z., Yang J.Y., Guo Y., Liu Y.X., Zhong X.Y. Altered levels of circulating mitochondrial DNA in elderly people with sarcopenia: Association with mitochondrial impairment. Exp. Gerontol., 2022, Vol. 163, 111802. doi: 10.1016/j.exger.2022.111802.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Gong T., Liu L., Jiang W., Zhou R. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat. Rev. Immunol., 2020, Vol. 20, no. 2, pp. 95-112.</mixed-citation><mixed-citation xml:lang="en">Gong T., Liu L., Jiang W., Zhou R. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat. Rev. Immunol., 2020, Vol. 20, no. 2, pp. 95-112.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kochlik B., Franz K., Henning T., Weber D., Wernitz A., Herpich C., Jannasch F., Aykaç V., Müller-Werdan U., Schulze M.B., Grune T., Norman K. Frailty is characterized by biomarker patterns reflecting inflammation or muscle catabolism in multi-morbid patients. J. Cachexia Sarcopenia Muscle, 2023, Vol. 14, no. 1, pp. 157-166.</mixed-citation><mixed-citation xml:lang="en">Kochlik B., Franz K., Henning T., Weber D., Wernitz A., Herpich C., Jannasch F., Aykaç V., Müller-Werdan U., Schulze M.B., Grune T., Norman K. Frailty is characterized by biomarker patterns reflecting inflammation or muscle catabolism in multi-morbid patients. J. Cachexia Sarcopenia Muscle, 2023, Vol. 14, no. 1, pp. 157-166.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Nelke C., Dziewas R., Minnerup J., Meuth S.G., Ruck T. Skeletal muscle as potential central link between sarcopenia and immune senescence. EBioMedicine, 2019, Vol. 49, pp. 381-388.</mixed-citation><mixed-citation xml:lang="en">Nelke C., Dziewas R., Minnerup J., Meuth S.G., Ruck T. Skeletal muscle as potential central link between sarcopenia and immune senescence. EBioMedicine, 2019, Vol. 49, pp. 381-388.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Picca A., Coelho-Junior H.J., Calvani R., Marzetti E., Vetrano D.L. Biomarkers shared by frailty and sarcopenia in older adults: A systematic review and meta-analysis. Ageing Res. Rev., 2022, Vol. 73, 101530. doi: 10.1016/j.arr.2021.101530.</mixed-citation><mixed-citation xml:lang="en">Picca A., Coelho-Junior H.J., Calvani R., Marzetti E., Vetrano D.L. Biomarkers shared by frailty and sarcopenia in older adults: A systematic review and meta-analysis. Ageing Res. Rev., 2022, Vol. 73, 101530. doi: 10.1016/j.arr.2021.101530.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Rong Y.D., Bian A.L., Hu H.Y., Ma Y., Zhou X.Z. Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10. BMC Geriatr., 2018, Vol. 18, no. 1, 308. doi: 10.1186/s12877-018-1007-9.</mixed-citation><mixed-citation xml:lang="en">Rong Y.D., Bian A.L., Hu H.Y., Ma Y., Zhou X.Z. Study on relationship between elderly sarcopenia and inflammatory cytokine IL-6, anti-inflammatory cytokine IL-10. BMC Geriatr., 2018, Vol. 18, no. 1, 308. doi: 10.1186/s12877-018-1007-9.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Sapan H.B., Paturusi I., Jusuf I., Patellongi I., Massi M.N., Pusponegoro A.D., Arief S.K., Labeda I., Islam A.A., Rendy L., Hatta M. Pattern of cytokine (IL-6 and IL-10) level as inflammation and anti-inflammation mediator of multiple organ dysfunction syndrome (MODS) in polytrauma. Int. J. Burns Trauma, 2016, Vol. 6, no. 2, pp. 37-43.</mixed-citation><mixed-citation xml:lang="en">Sapan H.B., Paturusi I., Jusuf I., Patellongi I., Massi M.N., Pusponegoro A.D., Arief S.K., Labeda I., Islam A.A., Rendy L., Hatta M. Pattern of cytokine (IL-6 and IL-10) level as inflammation and anti-inflammation mediator of multiple organ dysfunction syndrome (MODS) in polytrauma. Int. J. Burns Trauma, 2016, Vol. 6, no. 2, pp. 37-43.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Sari S.D.P., Listiyaningsih E., Mawanti W.T., Martalena D. Anti-Inflammatory Cytokine (IL-10) Profiles and Ratio of IL-6/IL-10 in Covid-19 Patients. MMJ, 2024, Vol. 5, no. 1, pp. 1-8.</mixed-citation><mixed-citation xml:lang="en">Sari S.D.P., Listiyaningsih E., Mawanti W.T., Martalena D. Anti-Inflammatory Cytokine (IL-10) Profiles and Ratio of IL-6/IL-10 in Covid-19 Patients. MMJ, 2024, Vol. 5, no. 1, pp. 1-8.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Wilson D., Jackson T., Sapey E., Lord J.M. Frailty and sarcopenia: The potential role of an aged immune system. Ageing Res. Rev., 2017, Vol. 36, pp. 1-10.</mixed-citation><mixed-citation xml:lang="en">Wilson D., Jackson T., Sapey E., Lord J.M. Frailty and sarcopenia: The potential role of an aged immune system. Ageing Res. Rev., 2017, Vol. 36, pp. 1-10.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Xu Y., Wang M., Chen D., Jiang X., Xiong Z. Inflammatory biomarkers in older adults with frailty: a systematic review and meta-analysis of cross-sectional studies. Aging Clin. Exp. Res., 2022, Vol. 34, no. 5, pp. 971-987.</mixed-citation><mixed-citation xml:lang="en">Xu Y., Wang M., Chen D., Jiang X., Xiong Z. Inflammatory biomarkers in older adults with frailty: a systematic review and meta-analysis of cross-sectional studies. Aging Clin. Exp. Res., 2022, Vol. 34, no. 5, pp. 971-987.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
